What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Published:2018-05-24 Issue:2 Volume:17 Page:149-160
ISSN:1723-8617
Container-title:World Psychiatry
language:en
Short-container-title:World Psychiatry

Author:

Correll Christoph U.¹²³⁴,Rubio Jose M.¹²³,Kane John M.¹²³

Affiliation:

1. Zucker Hillside Hospital, Psychiatry Research, Northwell Health; Glen Oaks NY USA

2. Hofstra Northwell School of Medicine; Hempstead NY USA

3. Feinstein Institute for Medical Research; Manhasset NY USA

4. Department of Child and Adolescent Psychiatry; Charité Universitätsmedizin; Berlin Germany

Publisher

Wiley

Subject

Psychiatry and Mental health,Pshychiatric Mental Health

Reference156 articles.

1. Schizophrenia;Kahn;Nat Rev Dis Primer,2015

2. Practice guideline for the treatment of patients with schizophrenia, 2nd ed;Lehman;Am J Psychiatry,2004

3. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements;Buchanan;Schizophr Bull,2010

4. Canadian schizophrenia guidelines: schizophrenia and other psychotic disorders with coexisting substance use disorders;Crockford;Can J Psychiatry,2017

5. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders;Galletly;Aust N Z J Psychiatry,2016

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serious Mental Illness;Massachusetts General Hospital Comprehensive Clinical Psychiatry;2025

2. Psychosis and Schizophrenia;Massachusetts General Hospital Comprehensive Clinical Psychiatry;2025

3. Novel long-acting treatment for schizophrenia based on paliperidone dissolving and implantable microarray patches;European Journal of Pharmaceutics and Biopharmaceutics;2024-11

4. Does relapse cause illness progression in first-episode psychosis? A review;Schizophrenia Research;2024-09

5. Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS);BMC Pharmacology and Toxicology;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3